Chongqing Bofeng Microsphere Technology

Chongqing Bofeng Microsphere Technology is a specialized biotechnology company focused on the research, development, and large-scale production of high-performance chromatography microspheres and advanced drug delivery systems. The company provides a comprehensive suite of separation and purification materials, including silica and polymer-based microspheres used extensively in the downstream processing of biopharmaceuticals such as insulin, GLP-1 analogs, and monoclonal antibodies. Beyond purification, Bofeng offers a proprietary platform for sustained-release microsphere formulations, providing CDMO services for complex injectable drugs that require long-acting delivery profiles. Their technology is designed to provide high-purity materials that serve as domestic alternatives to imported chromatography resins in the Chinese pharmaceutical market.